{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:31:37Z","timestamp":1772767897205,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12884-014-0411-1","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T19:05:49Z","timestamp":1418151949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review"],"prefix":"10.1186","volume":"14","author":[{"given":"Trina M","family":"Fyfe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Jane","family":"Ritchey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christorina","family":"Taruc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Crompton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Galliford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"issue":"12","key":"411_CR1","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1111\/j.0041-1132.2003.00632.x","volume":"43","author":"J Bowman","year":"2003","unstructured":"Bowman J: Thirty-five years of Rh prophylaxis. Transfusion. 2003, 43 (12): 1661-1666. 10.1111\/j.0041-1132.2003.00632.x.","journal-title":"Transfusion"},{"issue":"1","key":"411_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1054\/blre.1999.0123","volume":"14","author":"SJ Urbaniak","year":"2000","unstructured":"Urbaniak SJ, Greiss MA: RhD haemolytic disease of the fetus and the newborn. Blood Rev. 2000, 14 (1): 44-61. 10.1054\/blre.1999.0123.","journal-title":"Blood Rev"},{"key":"411_CR3","volume-title":"Cochrane Database Syst Rev","author":"CA Crowther","year":"2013","unstructured":"Crowther CA, Middleton P, McBain RD: Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev. 2013, 2:"},{"key":"411_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2393-14-87","volume":"14","author":"J Kent","year":"2014","unstructured":"Kent J, Farrell AM, Soothill P: Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice. BMC Pregnancy Childbirth. 2014, 14: 87-10.1186\/1471-2393-14-87.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9","key":"411_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1701-2163(16)31006-4","volume":"25","author":"KFK Fung","year":"2003","unstructured":"Fung KFK, Eason E: Prevention of Rh alloimmunization. J Obstet Gynaecol Can. 2003, 25 (9): 765-773.","journal-title":"J Obstet Gynaecol Can"},{"key":"411_CR6","unstructured":"Prevention of Rh Sensitization: Report of a WHO scienctific group. World Health Organization Technical Report Series No 468. 1971, World Health Organization, Geneva"},{"key":"411_CR7","doi-asserted-by":"crossref","unstructured":"ACOG practice bulletin: Prevention of Rh D alloimmunization. Int J Gynecology and Obstetrics. 1999, 66 (1): 63-70. 10.1016\/S0020-7292(99)90000-0.","DOI":"10.1016\/S0020-7292(99)90000-0"},{"key":"411_CR8","unstructured":"Routine antenatal anti-D prophylaxis for women who are rhesus D negative: Review of NICE technology appraisal guidance 41. NICE technology appraisal guidance 156. 2008, NICE, London, 1-27."},{"key":"411_CR9","volume-title":"Review of TA156; Pregnancy - routine anti-D prophylaxis for rhesus negative women (review of TA41)","author":"T Prices","year":"2011","unstructured":"Prices T, Rogers G, Holden J, Bibi M, Kenyon A, Willett S, McFarlane E: Review of TA156; Pregnancy - routine anti-D prophylaxis for rhesus negative women (review of TA41). 2011, National Institute for Health and Clinical Excellence, London, United Kingdom"},{"key":"411_CR10","unstructured":"Guidelines on the prophylactic use of Rh D immunoglobulin (anti-D) in obstetrics. 2003, National Blood Authority, Australia"},{"issue":"10","key":"411_CR11","first-page":"1","volume":"52","author":"J Martin","year":"2003","unstructured":"Martin J, Hamilton B, Sutton P, Ventura S, Menacker F, Munson M: Births: Final data for 2002. Natl Vital Stat Rep. 2003, 52 (10): 1-114.","journal-title":"Natl Vital Stat Rep"},{"issue":"5","key":"411_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1701-2163(16)35239-2","volume":"34","author":"L Koby","year":"2012","unstructured":"Koby L, Grunbaum A, Benjamin A, Koby R, Abenhaim HA: Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?. J Obstet Gynaecol Can. 2012, 34 (5): 429-435.","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"411_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.annemergmed.2011.11.010","volume":"59","author":"RT Griffey","year":"2012","unstructured":"Griffey RT, Chen BC, Krehbiel NW: Performance in appropriate Rh testing and treatment with Rh immunoglobulin in the emergency department. Ann Emerg Med. 2012, 59 (4): 285-293. 10.1016\/j.annemergmed.2011.11.010.","journal-title":"Ann Emerg Med"},{"key":"411_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1748-5908-5-69","volume":"5","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK: Scoping studies: advancing the methodology. Implement Sci. 2010, 5: 69-10.1186\/1748-5908-5-69.","journal-title":"Implement Sci"},{"issue":"10","key":"411_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.jclinepi.2006.01.007","volume":"59","author":"M Sampson","year":"2006","unstructured":"Sampson M, McGowan J: Errors in search strategies were identified by type and frequency. J Clin Epidemiol. 2006, 59 (10): 1057-1063. 10.1016\/j.jclinepi.2006.01.007.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"411_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/tme.12091","volume":"24","author":"H Qureshi","year":"2014","unstructured":"Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, Jones J, Allard S: BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014, 24 (1): 8-20. 10.1111\/tme.12091.","journal-title":"Transfus Med"},{"issue":"7","key":"411_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/1471-0528.12175","volume":"120","author":"PH Bolton-Maggs","year":"2013","unstructured":"Bolton-Maggs PH, Davies T, Poles D, Cohen H: Errors in anti-D immunoglobulin administration: retrospective analysis of 15\u00a0years of reports to the UK confidential haemovigilance scheme. BJOG. 2013, 120 (7): 873-878. 10.1111\/1471-0528.12175.","journal-title":"BJOG"},{"issue":"5","key":"411_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1365-3148.2007.00777.x","volume":"17","author":"B Chaffe","year":"2007","unstructured":"Chaffe B, Ford J, Bills V: Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen. Transfus Med. 2007, 17 (5): 399-403. 10.1111\/j.1365-3148.2007.00777.x.","journal-title":"Transfus Med"},{"issue":"4","key":"411_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1471-0528.1994.tb13613.x","volume":"101","author":"RG Hughes","year":"1994","unstructured":"Hughes RG, Craig JI, Murphy WG, Greer IA: Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985\u20131990. Br J Obstetrics & Gynaecology. 1994, 101 (4): 297-300. 10.1111\/j.1471-0528.1994.tb13613.x.","journal-title":"Br J Obstetrics & Gynaecology"},{"issue":"5","key":"411_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1471-0528.1999.tb08304.x","volume":"106","author":"IZ MacKenzie","year":"1999","unstructured":"MacKenzie IZ, Bowell P, Gregory H, Pratt G, Guest C, Entwistle CC: Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10\u00a0year study. Br J Obstetrics & Gynaecology. 1999, 106 (5): 492-497. 10.1111\/j.1471-0528.1999.tb08304.x.","journal-title":"Br J Obstetrics & Gynaecology"},{"issue":"7","key":"411_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1471-0528.2006.00988.x","volume":"113","author":"IZ MacKenzie","year":"2006","unstructured":"MacKenzie IZ, Findlay J, Thompson K, Roseman F: Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14\u00a0years. BJOG. 2006, 113 (7): 839-843. 10.1111\/j.1471-0528.2006.00988.x.","journal-title":"BJOG"},{"issue":"7122","key":"411_CR22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/bmj.315.7122.1588","volume":"315","author":"S Mayne","year":"1997","unstructured":"Mayne S, Parker JH, Harden TA, Dodds SD, Beale JA: Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme. BMJ. 1997, 315 (7122): 1588-10.1136\/bmj.315.7122.1588.","journal-title":"BMJ"},{"key":"411_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1471-0528.1998.tb09941.x","volume":"105","author":"E McSweeny","year":"1998","unstructured":"McSweeny E, Kirkham J, Vinall P, Flanagan P: An audit of anti-D sensitisation in Yorkshire. Br J Obstetrics & Gynaecology. 1998, 105: 1091-1094. 10.1111\/j.1471-0528.1998.tb09941.x.","journal-title":"Br J Obstetrics & Gynaecology"},{"issue":"1","key":"411_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1471-0528.1997.tb10646.x","volume":"104","author":"HL Howard","year":"1997","unstructured":"Howard HL, Martlew VJ, McFadyen IR, Clarke CA: Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?. Br J Obstetrics & Gynaecology. 1997, 104 (1): 37-41. 10.1111\/j.1471-0528.1997.tb10646.x.","journal-title":"Br J Obstetrics & Gynaecology"},{"issue":"3","key":"411_CR25","first-page":"150","volume":"59","author":"I Rennie","year":"2001","unstructured":"Rennie I, Smith A, Smith R, Rawlinson PS, Clark P: An audit of the investigation and use of anti-D immunoglobulin prophylaxis in Tayside. Health Bull. 2001, 59 (3): 150-154.","journal-title":"Health Bull"},{"issue":"6","key":"411_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/01443619963851","volume":"19","author":"R Fox","year":"1999","unstructured":"Fox R, Savage R, Evans T, Moore L: Early pregnancy assessment; A role for the gynaecology nurse-practitioner. J Obstet Gynaecol. 1999, 19 (6): 615-616. 10.1080\/01443619963851.","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"411_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0196-0644(05)80162-3","volume":"21","author":"J Grant","year":"1992","unstructured":"Grant J, Hyslop M: Underutilization of Rh prophylaxis in the emergency department: a retrospective survey. Ann Emerg Med. 1992, 21 (2): 181-183. 10.1016\/S0196-0644(05)80162-3.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"411_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/emj.10.4.306","volume":"10","author":"AM Huggon","year":"1993","unstructured":"Huggon AM, Watson DP: Use of anti-D in an accident and emergency department. Arch Emerg Med. 1993, 10 (4): 306-309. 10.1136\/emj.10.4.306.","journal-title":"Arch Emerg Med"},{"issue":"2","key":"411_CR29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5694\/j.1326-5377.2002.tb04285.x","volume":"176","author":"B McLaren","year":"2002","unstructured":"McLaren B, Shelley JM: Reported management of early-pregnancy bleeding and miscarriage by general practitioners in Victoria. Medical J Australia. 2002, 176 (2): 63-66.","journal-title":"Medical J Australia"},{"issue":"6","key":"411_CR30","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/emj.18.6.444","volume":"18","author":"L Weinberg","year":"2001","unstructured":"Weinberg L: Use of anti-D immunoglobulin in the treatment of threatened miscarriage in the accident and emergency department. Emerg Med J. 2001, 18 (6): 444-447. 10.1136\/emj.18.6.444.","journal-title":"Emerg Med J"},{"issue":"2","key":"411_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/OGX.0b013e31816016fc","volume":"63","author":"JM Thorp","year":"2008","unstructured":"Thorp JM: Utilization of anti-RhD in the emergency department after blunt trauma. Obstet Gynecol Surv. 2008, 63 (2): 112-115. 10.1097\/OGX.0b013e31816016fc.","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"411_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/003693309403900509","volume":"39","author":"S Ghosh","year":"1994","unstructured":"Ghosh S, Murphy WG: Implementation of the rhesus prevention programme: a prospective study. Scott Med J. 1994, 39 (5): 147-149.","journal-title":"Scott Med J"},{"key":"411_CR33","unstructured":"Rh Program of Nova Scotia [], [ http:\/\/rcp.nshealth.ca\/rh ]"},{"issue":"2","key":"411_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1377\/hlthaff.2012.1078","volume":"32","author":"F Legare","year":"2013","unstructured":"Legare F, Witteman HO: Shared decision making: examining key elements and barriers to adoption into routine clinical practice. Health Aff. 2013, 32 (2): 276-284. 10.1377\/hlthaff.2012.1078.","journal-title":"Health Aff"},{"key":"411_CR35","first-page":"1","volume-title":"Research White Paper","author":"M O\u2019Neil","year":"2014","unstructured":"O\u2019Neil M, Berkman N, Hartling L, Chang S, Anderson J, Motu\u2019apuaka M, Guise J, McDonagh M: Observational evidence and strength of evidence domains: case examples. Research White Paper. 2014, Scientific Resource Centre, Portland, OR, 1-12."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-014-0411-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-014-0411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-014-0411-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T18:43:38Z","timestamp":1598553818000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-014-0411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1186\/s12884-014-0411-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"article-number":"411"}}